We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
(-14%)
Cap. Flow
-$2.77B
Cap. Flow
% of AUM
-10.63%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$49.4M |
| 2 |
Nucor
NUE
|
+$35.6M |
| 3 |
Essex Property Trust
ESS
|
+$27.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$27.3M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$366M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Amazon
AMZN
|
+$213M |
| 4 |
Tesla
TSLA
|
+$109M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.74% |
| 2 | Consumer Staples | 11.79% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Industrials | 10.74% |
| 5 | Healthcare | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Tetra Tech
TTEK
$8.23B
| $393K | ﹤0.01% |
15,300
-255
| -2% | -$7.14K |
|
1002
Unity
U
$12.5B
| $393K | ﹤0.01% |
12,321
+121
| +1% | +$4.98K |
|
1003
Simply Good Foods
SMPL
$904M
| $392K | ﹤0.01% |
12,251
-404
| -3% | -$13.3K |
|
1004
Commault Systems
CVLT
$5.89B
| $391K | ﹤0.01% |
7,358
-95
| -1% | -$5.39K |
|
1005
BILL Holdings
BILL
$4.33B
| $388K | ﹤0.01% |
2,933
-538
| -15% | -$77.3K |
|
1006
Bloom Energy
BE
$52.6B
| $387K | ﹤0.01% |
19,388
+1,095
| +6% | +$24.7K |
|
|
ONEM
1007
DELISTED
1Life Healthcare
ONEM
| $387K | ﹤0.01% |
22,549
-539
| -2% | -$8.46K |
|
1008
H&R Block
HRB
$5.18B
| $386K | ﹤0.01% |
9,053
-99
| -1% | -$4.19K |
|
1009
Vishay Intertechnology
VSH
$5.86B
| $386K | ﹤0.01% |
21,721
-384
| -2% | -$7.49K |
|
1010
Helen of Troy
HELE
$663M
| $385K | ﹤0.01% |
3,971
-56
| -1% | -$7.2K |
|
1011
Twist Bioscience
TWST
$5.62B
| $385K | ﹤0.01% |
10,930
-680
| -6% | -$28.9K |
|
1012
Harmony Biosciences
HRMY
$2.04B
| $384K | ﹤0.01% |
8,673
+467
| +6% | +$22.8K |
|
1013
Supernus Pharmaceuticals
SUPN
$2.68B
| $384K | ﹤0.01% |
11,361
+164
| +1% | +$5.34K |
|
1014
Werner Enterprises
WERN
$2.54B
| $384K | ﹤0.01% |
10,210
-347
| -3% | -$14.1K |
|
1015
Box
BOX
$4.02B
| $383K | ﹤0.01% |
15,735
+908
| +6% | +$25K |
|
1016
Rambus
RMBS
$10.4B
| $383K | ﹤0.01% |
15,095
-383
| -2% | -$9.57K |
|
|
MRTX
1017
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $383K | ﹤0.01% |
5,475
+331
| +6% | +$24.5K |
|
1018
Chemours
CC
$2.59B
| $382K | ﹤0.01% |
15,494
-691
| -4% | -$22.8K |
|
1019
Arcosa
ACA
$7.12B
| $381K | ﹤0.01% |
6,656
-173
| -3% | -$9.59K |
|
|
AXNX
1020
DELISTED
Axonics, Inc. Common Stock
AXNX
| $381K | ﹤0.01% |
5,404
+128
| +2% | +$8.83K |
|
1021
Resideo Technologies
REZI
$5.23B
| $380K | ﹤0.01% |
19,912
-507
| -2% | -$10.8K |
|
1022
Brighthouse Financial
BHF
$3.63B
| $379K | ﹤0.01% |
8,745
-675
| -7% | -$30.7K |
|
|
RVNC
1023
DELISTED
Revance Therapeutics, Inc.
RVNC
| $379K | ﹤0.01% |
14,057
+516
| +4% | +$10.5K |
|
1024
Envista
NVST
$4.28B
| $378K | ﹤0.01% |
11,530
-70
| -0.6% | -$2.65K |
|
1025
Bruker
BRKR
$9.2B
| $377K | ﹤0.01% |
7,107
-27
| -0.4% | -$1.61K |
|
Similar funds
ProShare Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.
- ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
- ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
- ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
- ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
- ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
- ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
- ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.
Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.